Skip to main content
Clinical Trials/NCT02642198
NCT02642198
Unknown
N/A

Clinical Investigation for Non-invasive Blood Pressure Monitor Accuracy Validation Performed on Neonatal, Infants and Children up to 3 Years Old

Mortara Instrument2 sites in 1 country25 target enrollmentOctober 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Non-invasive Blood Pressure
Sponsor
Mortara Instrument
Enrollment
25
Locations
2
Primary Endpoint
To study is the non-invasive blood pressure measurements accuracy validation performed with the Surveyor S12 / S19 monitor in pediatric, infants and children up to 3 years patients per ISO 81060-2: 2013 requirements.
Last Updated
10 years ago

Overview

Brief Summary

This study is being conducted to validate the accuracy of non-invasive blood pressure (NIBP) measurement technology from Mortara Instrument, Inc. (Milwaukee, Wisconsin, USA) and Zoe Medical, Inc. (Topsfield, Massachusetts, USA) in a neonatal, infants and children up to 3 years old patient population. The study is defined according to the International Standard "ANSI/AAMI/ISO 81060-2:2013, Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type".

Detailed Description

The device under test is Mortara Instrument's Surveyor S12/S19 patient monitors ("Surveyor") incorporating neonatal NIBP technology. Specifically, NIBP measurements will be taken using a cuff on the patient's limb (exact location will be determined by clinician) using a variety of cuffs sized for neonates and pediatrics. The device utilizes oscillometric technology to obtain quickly and conveniently non-invasive blood pressure measurements. Results will be compared to invasive blood pressure measurements from patients already monitored with such sensors. The Device under Test will be calibrated and verified by a Mortara representative on site.

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
March 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Mortara Instrument
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

To study is the non-invasive blood pressure measurements accuracy validation performed with the Surveyor S12 / S19 monitor in pediatric, infants and children up to 3 years patients per ISO 81060-2: 2013 requirements.

Time Frame: 4 hours per patient

To study the accuracy of non-invasive blood pressure measurements in neonatal patients

Study Sites (2)

Loading locations...

Similar Trials